1Williamson B D，New England J Medicine，1994年，311卷，910页
21，Rosenqvist M,Lee MA,Moulinier L,et al.Long-termfollow-up of patients after transcatheter direct current ablation of the atrioventricularjunction.J Am Coll Cardiol,1990,16∶1467-1474.
32，Grogan M,Smith HC,Gersh BJ,et al.Left vertricular dysfunction due to atrialfibrillation in patients initially believed to have idiopathic dilated cardiomyopathy.Am JCardiol,1992,69∶1570-1573.
43，Packer D，Bardy GH,Worley GH,et al.Tachycardia induced cardiomyopathy:a reversibleform of left ventricular dysfunction.Am J Cardiol,1986,57∶563-570.
54，Peters KG,Kienzle MG.Severe cardiomyopathy due to severe chronic rapid atrialfibrillation:complete recovery after reversion to sinus rhythm.Am J Med,1988,85∶242-244.
65，Meijler FL.An“account” of digitalis and atrial fibrillation.J Am CollCardiol,1985,5∶60A-68A.
76，Van den Berg MP,De Langen CDJ,Crijns HJGM,et al.Effect of metoprolol on atrialfibrillatory rate,atrioventricular nodal concealed conduction and ventricular responseduring atrial fibrillation in pigs.J Cardiovasc Pharm,1994,23∶846-851.
87，Di Bianco R,Morganroth J,Freitag RJ.Effect of nodolol on the spontaneous and exerciseprovoked heart rate in patients with chronic atrial fibrillation receiving stable doses ofdigoxin.Am Heart J,1984,108∶1121-1127.
98，Atwood JE,Sullivan M,Forbes S.Effects of beta-adrenergic blockade on exerciseperformance in patients with chronic atrial fibrillation.J Am Coll Cardiol,1987,10∶314-320.
109，Lang R,Klein H,Segni E.Verapamil improves exercise capacity in chronic atrialfibrillation:double-blind cross over study.Am Heart J,1983,105∶820-824.
4Reiffel JA.Drug choices in the treatment of atrial fibrilla-tion.Am J Cardio,2000,85:12～19.
5AFFIRM first anti arrhythmic drug substudy investigators.Maintenance of sinus rhythm in patients with atrial fibrillation:an AFFIRM substudy of the first antiarrhythmic drug.J Am Coll Cardio,2003,42:20～29.
6Boss CJ.More RS.Anticoagulation for non-valvular artiallation towards a new beginning with ximeclagatran.Curr Control Trials Cardiovasc Med,2004,5(1):3.
7NataleA,Raviele A,Arentz T,et al.Venice chart international consensus document on atrial fibrillation ablation.Journal of cardio vascularelec-trophysiology,2007,18 (5):560～580.
8Zaman AG,KearneyMT,Schecter C,et al.Angiotensin-converting enzyme inhibitors as adjuvent therapy in patientswith persistent atrial fibrillation.Am Heart J,2004,147:823～827.
9KumagaiK,NakashimaH,UrataH,etal.Effects ofangio-tensinⅡtypel receptor antagoniston electrical and structur-al remodeling in atrial fibrillation.JAm CollCardio,2003,41:2 197～2 204.
10Siu CW,Lau CP,Tse HF.Prevention of atrial fibrillationrecurrence by statin therapy in patientswith lone atrial fibril-lation after successful cardioversion.Am JCardio,2003,92(11):1 343～1 345.
